Exposure to Vaping During Pregnancy Linked to Skull Development in Babies
:max_bytes(150000):strip_icc():format(jpeg)/vaping-study-071825-023f76aaee9d4796a8ebbb1acb6b1d07.jpg)
A recent study has revealed that exposure to vaping ingredients during pregnancy can impact the shape of a baby’s skull, even without the presence of nicotine. Researchers from Ohio State University carried out experiments on pregnant mice, determining that the liquid components in e-cigarettes could significantly affect fetal development. The study sheds new light on the potential risks of vaping for pregnant individuals and their unborn children.
The findings of the study, published in the journal PLOS One, highlighted the effects of two specific liquids used in e-cigarettes on pregnant mice. Despite the absence of nicotine, the offspring of mice exposed to these vape ingredients exhibited issues such as lower birth weights, shortened skulls, and narrower facial features compared to control groups. These unexpected results emphasised the impact of vaping on fetal development.

Lead author of the study, James Cray, a professor of anatomy at Ohio State University College of Medicine, expressed surprise at the outcomes. The research focused on the effects of humectants, substances that help carry e-cigarette contents, including propylene glycol and glycerol. Results showed that exposure to these substances led to notable reductions in cranial width and height in the offspring of the mice studied.
The study involved exposing pregnant mice to different concentrations of the vape ingredients over a three-week period, mimicking a typical vaping schedule. Interestingly, the research indicated that a higher proportion of propylene glycol, commonly found in e-cigarettes, had more pronounced effects on skull development than other mixtures. This observation challenges the notion that certain e-cigarette ingredients are safer alternatives.

Nicotine, a well-known harmful substance, has been linked to various adverse effects on children’s health, including developmental issues and birth defects. The study’s findings underscore the importance of understanding the potential risks associated with e-cigarettes, particularly for young adults and teenagers who are frequent users of these products. With ongoing legal battles over e-cigarette regulation, it is crucial to prioritise research on the safety of vaping alternatives without nicotine.
As the study suggests, further investigation is needed to evaluate the safety of nicotine-free vaping products and their potential impact on pregnancy outcomes. The implications of these findings extend to public health initiatives aimed at raising awareness about the risks of vaping during pregnancy and the importance of informed decision-making among individuals of reproductive age.
In light of these research findings, health professionals and policymakers are called upon to consider the broader implications of vaping on maternal and child health. The study serves as a reminder of the complexities of e-cigarette use and the need for comprehensive approaches to safeguarding the health and well-being of pregnant individuals and their offspring. Further research in this area is essential to inform public health strategies and regulatory measures concerning vaping and its impact on prenatal development.
